Insulin-like growth factor II (IGF II) in human brain: regional distribution of IGF II and of higher molecular mass forms.
Twenty-four distinct areas of human brain were analyzed for the presence of insulin-like growth factor (IGF). As reported for cerebrospinal fluid, only IGF II-like immunoreactivity, but no significant amounts of IGF I-like immunoreactivity, could be found. Upon gel permeation chromatography, two to five distinct size classes were separated on the basis of their immunoreactivity. The smallest component had an apparent molecular mass of 7.5 kDa, identical to the one of purified IGF II from human serum. Radioimmunoassays and a bioassay also gave results indistinguishable from those of serum IGF II. The highest amounts of IGF II-like immunoreactivity occur in the anterior pituitary--namely, 20-25 pmol equivalents/g of wet weight. This is up to 100 times more than in most other brain regions analyzed. The higher molecular mass immunoreactive species were partially characterized. After immunoaffinity purification, the 38- and 26-kDa species are active in a bioassay. Specific IGF-binding protein activity could be shown after purification of the 38- and 26-kDa species on an IGF-affinity column. The 13-kDa species released significant amounts of 7.5-kDa material. The results are interpreted as evidence for the presence of IGF II synthesized locally in human brain. The structure of the larger forms of IGF II-like immunoreactive material as well as the function of IGF II in brain are not yet known.
D001923:Brain Chemistry; D002850:Chromatography, Gel; D006801:Humans; D007328:Insulin / Q000276:immunology / Q000302:isolation & purification* / Q000502:physiology; D008970:Molecular Weight; D010455:Peptides / Q000276:immunology / Q000302:isolation & purification* / Q000502:physiology; D013002:Somatomedins / Q000276:immunology / Q000302:isolation & purification* / Q000502:physiology
D007328:Insulin; D010455:Peptides; D013002:Somatomedins